将重组抗原输送到树突细胞是改善疫苗设计的一种方式
Guilherme Antonio de Souza-Silva1, Fernando Bandeira Sulczewski1, Silvia Beatriz Boscardin1,2
1Departamento de Parasitologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, 05508-000, Brazil.
Experimental biology and medicine (Maywood, N.J.)
|September 26, 2023
概括
化学单克隆抗体将抗原传递给树突细胞,增强免疫反应. 这种向的抗原输送显示了提高针对各种病原体的疫苗疗效的希望.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 树突细胞对于启动抗原特异性免疫反应至关重要.
- 了解树突细胞子集是调节免疫发育的关键.
研究的目的:
- 审查树突细胞生物学和子集对免疫的影响.
- 探索使用嵌合性单克隆抗体来向向树突细胞输送抗原.
主要方法:
- 审查关于树突细胞生物学现有知识.
- 对化单克隆抗体的探索,这些抗体准C型莱克受体.
- 对抗体-抗原融合用于抗原输送的临床前研究的分析.
主要成果:
- 化学抗体可以将抗原直接输送到树突细胞子集.
- 这种有针对性的方法可以调节对病原体的免疫反应.
- 临床前数据支持这种策略的潜力.
结论:
- 通过仿真单克隆抗体进行向的抗原递送,为疫苗开发提供了一种新的方法.
- 这种方法有望提高针对各种病原体的疫苗疗效.
相关概念视频
Vaccinations
44.6K
Overview
44.6K
Cancer Vaccines
396
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
396
Antigens Involved in Adaptive Immunity
528
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
528


